Wave Neuroscience Acquires Assets of NeoSync

Wave Neuroscience, Inc., a global leader in developing personalized, noninvasive technology aimed at addressing neurological disorders and enhancing cognitive brain function through Transcranial Magnetic Stimulation (TMS), announced today that it has acquired the assets of NeoSync, Inc. NeoSync is a pioneer in personalized, low-energy brain stimulation for the treatment of Major Depressive Disorder and other diseases of the Central Nervous System (CNS). Among the assets acquired are 19 issued and four pending patents which will be added to Wave’s existing portfolio, strengthening Wave’s position in EEG and EEG/EKG guided TMS. In addition, Wave has acquired the Neuro-EEG Synchronization Therapy (NEST®) system developed and tested by NeoSync.

Read the full article: Wave Neuroscience Acquires Assets of NeoSync //

Source: https://www.globenewswire.com/news-release/2020/02/26/1991037/0/en/Wave-Neuroscience-Acquires-Assets-of-NeoSync.html

Scroll to Top